Kindred Biosciences News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

17.08.21	SHAREHOLDER ALERT: WeissLaw LLP Reminds KIN, SYKE, MNR, and QTS Shareholders About Its Ongoing Investigations (PR Newswire)
28.07.21	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates SYKE, TGRF, ONEM, KIN; Shareholders are Encouraged to Contact the Firm (PR Newswire)
21.07.21	SHAREHOLDER ALERT: WeissLaw LLP Reminds CVA, SWN, RIVE, and KIN Shareholders About Its Ongoing Investigations (PR Newswire)
17.07.21	SHAREHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger (PR Newswire)
14.07.21	SHAREHOLDER ALERT: WeissLaw LLP Reminds SWN, RIVE, CLDB, and KIN Shareholders About Its Ongoing Investigations (PR Newswire)
07.07.21	SHAREHOLDER ALERT: WeissLaw LLP Reminds RIVE, CLDB, KIN, and FMBI Shareholders About Its Ongoing Investigations (PR Newswire)
30.06.21	SHAREHOLDER ALERT: WeissLaw LLP Reminds CLDB, KIN, FMBI, and SLCT Shareholders About Its Ongoing Investigations (PR Newswire)
17.06.21	SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Kindred Biosciences, Inc. - KIN (PR Newswire)
17.06.21	ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kindred Biosciences, Inc. (PR Newswire)
16.06.21	Elanco Animal Health To Acquire Kindred Biosciences For About $440 Mln - Quick Facts (RTTNews)
16.06.21	Elanco Announces Agreement to Acquire Kindred Biosciences (PR Newswire)
11.12.20	Elanco Reaches Deal With Kindred To Acquire Global Rights To KIND-030 - Quick Facts (RTTNews)
07.10.20	Kindred Expands Manufacturing Deal With Vaxart For COVID-19 And Other Vaccine Candidates (RTTNews)
16.09.20	Stock Alert: Kindred Biosciences Gains 17% (RTTNews)
01.09.20	ACST's CaPre Misses Goal Again, AIMT Snapped Up By Nestle, CRMD To Face FDA In Feb, VIR & COVID-19 (RTTNews)
20.05.20	Stock Alert: KindredBio Stock Up 16% On COVID-19 Vaccine Development News (RTTNews)
04.09.18	Is There Still Room To Run For These Biotech Stocks? (RTTNews)
21.06.18	It's Raining IPOs Today, ATOS To Report Data In Q3, KIN Well-Funded, STAA Shines (RTTNews)
30.05.18	KindredBio Announces Positive Results from Pilot Effectiveness Study of KIND-014 for the Treatment of Gastric Ulcers in Horses (PR Newswire)
29.05.18	Kindred Biosciences to Present at Jefferies 2018 Global Healthcare Conference and 8th Annual LD Micro Invitational Conference (PR Newswire)
24.05.18	Kindred Biosciences to Present at Stifel 2018 Dental & Veterinary Conference (PR Newswire)
08.05.18	Kindred Biosciences Announces First Quarter 2018 Financial Results (PR Newswire)
07.05.18	Kindred Biosciences Receives FDA Approval of Mirataz™ (mirtazapine transdermal ointment) for the Management of Weight Loss in Cats (PR Newswire)
25.04.18	Kindred Biosciences Announces the Appointment of Dr. Ernest Mario and Dr. Joseph McCracken to its Board of Directors (PR Newswire)
24.04.18	Kindred Biosciences Provides Updates on Pending Drug Approvals (PR Newswire)
24.04.18	Mack Trucks Rolls Out Refuse Vehicles Pre-Wired for Lytx® Programs (PR Newswire)
18.04.18	Kindred Biosciences to Announce First Quarter 2018 Financial Results (PR Newswire)
14.03.18	The Quail Motorcycle Gathering Weekend To Feature Cuisine From Michelin-Starred Chef Curtis Duffy and Executive Chef Ethan Mantle (PR Newswire)
08.03.18	Kindred Biosciences to Present at the Oppenheimer 28th Annual Healthcare Conference (PR Newswire)
01.03.18	Kindred Biosciences Announces Fourth Quarter and Full Year 2017 Financial Results (PR Newswire)
28.02.18	S&W Granted Patent for Stevia Variety SW227 for Fresh and Dry Leaf Market (PR Newswire)
15.02.18	Kindred Biosciences to Announce Fourth Quarter and Year-End 2017 Financial Results (PR Newswire)
13.02.18	Kindred Biosciences to Participate in the Bank of America Merrill Lynch Animal Health Summit (PR Newswire)
27.12.17	KindredBio Pulling Back Off Three-Year Closing High (RTTNews)
21.12.17	KindredBio Announces Submission of European Medicines Agency Filing for Mirataz™ (PR Newswire)
04.12.17	KindredBio Announces Positive Results from Pivotal Study of Zimeta Oral for Fever in Horses (PR Newswire)
07.11.17	Kindred Biosciences Announces Third Quarter 2017 Financial Results (PR Newswire)
30.10.17	Panda Express Celebrates 30 Years of Original Orange Chicken™ (PR Newswire)
11.10.17	Kindred Biosciences to Announce Third Quarter 2017 Financial Results (PR Newswire)
05.10.17	Kindred Biosciences to Participate in the Oppenheimer & Co. Specialty Pharmaceuticals Conference (PR Newswire)
11.09.17	Kindred Biosciences Announces Plans for Promotion of Dr. Zhan and Retirement of Dr. Sundlof (PR Newswire)
07.08.17	Kindred Biosciences Announces Second Quarter 2017 Financial Results (PR Newswire)
04.08.17	Kindred Biosciences Sponsors Veterinary Students to Attend the 2017 American Association of Feline Practitioners Meeting (PR Newswire)
24.07.17	Kindred Biosciences to Announce Second Quarter 2017 Financial Results (PR Newswire)
12.07.17	KindredBio Announces Pricing of Public Offering (PR Newswire)
15.06.17	Kindred Biosciences Added to the Russell 2000 Index (PR Newswire)
30.05.17	Kindred Biosciences to Present Data from Six Studies at the 2017 American College of Veterinary Internal Medicine Conference (PR Newswire)
24.05.17	Kindred Biosciences to Present at 7th Annual LD Micro Invitational (PR Newswire)
03.05.17	Kindred Biosciences Announces First Quarter 2017 Financial Results (PR Newswire)
01.05.17	Kindred Biosciences Announces Initiation of Enrollment in Pivotal Effectiveness Trial of Zimeta Oral for the Control of Fever in Horses (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Kindred Biosciences Inc

Aktien Top/Flop

Meistgelesene Nachrichten